Latest News and Blogs

We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).

We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine. 

Congenica announces a two-year extension to their contract with the Hong Kong Genome Project (HKGP).

Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.

Congenica Informatics Director Richard Durbin has been awarded the International Prize for Biology by the Japan Society of the Promotion of Science.

Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute. 

Congenica launches early access program for its new CE-IVD Precision Oncology Solution

Congenica is an approved supplier on UK Government G-Cloud 13 framework

Congenica awarded a contract to develop standardised NGS workflows in oncology for a group of 7 Central European hospitals by the Medical University Graz

Congenica and FDB announce a collaboration agreement to develop the delivery of pharmacogenomics (PGx) results into point of care prescribing.      

Congenica employees receive one off bonus to help with increases in cost of living

Congenica announces a partnership with Avesthagen, strengthenening Congenica’s presence in India